Levison L, Blicher J, Andersen H
J Neurol. 2024; 272(1):44.
PMID: 39666144
PMC: 11638285.
DOI: 10.1007/s00415-024-12743-0.
Puri S, Raghuveer R, Jachak S, Tikhile P
Cureus. 2024; 16(9):e68373.
PMID: 39360074
PMC: 11444842.
DOI: 10.7759/cureus.68373.
Metzger M, Dukic S, McMackin R, Giglia E, Mitchell M, Bista S
Hum Brain Mapp. 2023; 45(1):e26536.
PMID: 38087950
PMC: 10789208.
DOI: 10.1002/hbm.26536.
Xie M, Pallegar P, Parusel S, Nguyen A, Wu L
Mol Neurodegener. 2023; 18(1):75.
PMID: 37858176
PMC: 10585818.
DOI: 10.1186/s13024-023-00665-w.
Mcfarlane R, Peelo C, Galvin M, Heverin M, Hardiman O
Neurology. 2023; 101(19):e1905-e1912.
PMID: 37748881
PMC: 10663006.
DOI: 10.1212/WNL.0000000000207797.
Epidemiology of amyotrophic lateral sclerosis in the north east Tuscany in the 2018-2021 period.
Mata S, Bussotti M, Del Mastio M, Barilaro A, Piersanti P, Lombardi M
eNeurologicalSci. 2023; 31:100457.
PMID: 37008534
PMC: 10063398.
DOI: 10.1016/j.ensci.2023.100457.
Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy.
Gianferrari G, Martinelli I, Zucchi E, Simonini C, Fini N, Vinceti M
Biomedicines. 2022; 10(4).
PMID: 35453569
PMC: 9031824.
DOI: 10.3390/biomedicines10040819.
Amyotrophic Lateral Sclerosis: A Diet Review.
DAntona S, Caramenti M, Porro D, Castiglioni I, Cava C
Foods. 2021; 10(12).
PMID: 34945679
PMC: 8702143.
DOI: 10.3390/foods10123128.
Minor Allele Frequencies and Molecular Pathways Differences for SNPs Associated with Amyotrophic Lateral Sclerosis in Subjects Participating in the UKBB and 1000 Genomes Project.
DAntona S, Bertoli G, Castiglioni I, Cava C
J Clin Med. 2021; 10(15).
PMID: 34362180
PMC: 8348602.
DOI: 10.3390/jcm10153394.
Glucose Metabolic Dysfunction in Neurodegenerative Diseases-New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming.
Han R, Liang J, Zhou B
Int J Mol Sci. 2021; 22(11).
PMID: 34072616
PMC: 8198281.
DOI: 10.3390/ijms22115887.
DDX17 is involved in DNA damage repair and modifies FUS toxicity in an RGG-domain dependent manner.
Fortuna T, Kour S, Anderson E, Ward C, Rajasundaram D, Donnelly C
Acta Neuropathol. 2021; 142(3):515-536.
PMID: 34061233
PMC: 8856901.
DOI: 10.1007/s00401-021-02333-z.
Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy.
Damri O, Shemesh N, Agam G
Int J Mol Sci. 2020; 22(1).
PMID: 33375448
PMC: 7795249.
DOI: 10.3390/ijms22010189.
Home invasive mechanical ventilation in Finland in 2015-2019.
Kotanen P, Kreivi H, Vainionpaa A, Laaksovirta H, Brander P, Siirala W
ERJ Open Res. 2020; 6(4).
PMID: 33263031
PMC: 7682663.
DOI: 10.1183/23120541.00223-2020.
Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.
Casci I, Krishnamurthy K, Kour S, Tripathy V, Ramesh N, Anderson E
Nat Commun. 2019; 10(1):5583.
PMID: 31811140
PMC: 6898697.
DOI: 10.1038/s41467-019-13383-z.
A retrospective study of the clinical phenotype and predictors of survival in non-Caucasian Hispanic patients with amyotrophic lateral sclerosis.
Sanchez-Martinez C, Choreno-Parra J, Nunez-Orozco L, Placencia-Alvarez N, Alvis-Castano L, Guadarrama-Ortiz P
BMC Neurol. 2019; 19(1):261.
PMID: 31664949
PMC: 6819359.
DOI: 10.1186/s12883-019-1459-3.
Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials.
van den Berg L, Sorenson E, Gronseth G, Macklin E, Andrews J, Baloh R
Neurology. 2019; 92(14):e1610-e1623.
PMID: 30850440
PMC: 6448453.
DOI: 10.1212/WNL.0000000000007242.
The multistep hypothesis of ALS revisited: The role of genetic mutations.
Chio A, Mazzini L, DAlfonso S, Corrado L, Canosa A, Moglia C
Neurology. 2018; 91(7):e635-e642.
PMID: 30045958
PMC: 6105040.
DOI: 10.1212/WNL.0000000000005996.
Determining the incidence of familiality in ALS: A study of temporal trends in Ireland from 1994 to 2016.
Ryan M, Heverin M, Doherty M, Davis N, Corr E, Vajda A
Neurol Genet. 2018; 4(3):e239.
PMID: 29845113
PMC: 5961194.
DOI: 10.1212/NXG.0000000000000239.
Age-specific ALS incidence: a dose-response meta-analysis.
Marin B, Fontana A, Arcuti S, Copetti M, Boumediene F, Couratier P
Eur J Epidemiol. 2018; 33(7):621-634.
PMID: 29687175
DOI: 10.1007/s10654-018-0392-x.
Needs of informal caregivers across the caregiving course in amyotrophic lateral sclerosis: a qualitative analysis.
Galvin M, Carney S, Corr B, Mays I, Pender N, Hardiman O
BMJ Open. 2018; 8(1):e018721.
PMID: 29374665
PMC: 5829772.
DOI: 10.1136/bmjopen-2017-018721.